The importation of long-tailed macaques from Cambodia to Canada for medical research has sparked significant concerns over animal welfare and public health risks. The surge in imports began after Charles River Laboratories halted its shipments to the U.S. following a U.S. investigation into alleged illegal primate smuggling.

Increased Imports:
The value of Canadian imports of macaques from Cambodia has spiked nearly six times to roughly $62 million since Charles River Laboratories stopped importing to the U.S. in February 2023.

Alleged Wild Capture:
The U.S. alleges that the monkeys are being illegally captured from the wild, which raises concerns about zoonotic disease transmission and animal welfare.

Canadian Regulations:
Despite the concerns, Environment and Climate Change Canada and the Canadian Food Inspection Agency are closely inspecting the animals to ensure compliance with federal and international wildlife regulations.

Animal Advocacy:
Animal advocates, including People for the Ethical Treatment of Animals (PETA), are urging the Canadian government to halt the imports and address the potential public health risks.

Political Pressure:
The federal NDP is urging Ottawa to bring immediate attention to the issue, and opposition politicians are demanding action from the Liberal government.

Research Continuation:
Charles River Laboratories maintains that its research is essential for medical advances and that it follows strict safety protocols, despite the controversy.

We hope you enjoyed this article. Please feel free to leave a comment below if you want to engage in the discussion.

If you want to read more like this, make sure to check out our Blog and follow us on Instagram. If you are interested in truly sustainable products, check out our Shop.

Check out the original source here.